Among 2133 isolates of Escherichia coli obtained during 1996 from 10 Greek hospitals, 63 (3%) were resistant to cefoxitin. Typing by ERIC2-PCR indicated that the cefoxitin-resistant (FOX r ) isolates were distinct. -Lactamase studies and hybridization experiments showed that most strains produced -lactamases related to the AmpC chromosomal cephalosporinase of Citrobacter freundii. The enzymes were encoded by similar non-self-transmissible plasmids. The bla genes encoding two -lactamases (LAT-3 and LAT-4) with isoelectric points 8.9 and 9.4, respectively, were cloned and sequenced. The deduced amino acid sequences displayed a high degree of homology (>95%) with the AmpC -lactamase of C. freundii. The patterns of resistance to -lactams of the FOX r E. coli depended on the quantity of class C enzymes and the simultaneous expression of other -lactamases. In a few isolates a 36 kDa outermembrane protein, presumably a porin, was not expressed at detectable quantities. These isolates were resistant to cefoxitin, and their susceptibility to the other -lactams tested was not significantly decreased.
Introduction
Escherichia coli is one of the leading causes of nosocomial infections. The most frequent mechanism of resistance to penicillins is the production of the common plasmidmediated TEM-1 -lactamase. 1 Extended-spectrumlactamases of the TEM and SHV families, conferring resistance to newer -lactams such as oxyimino-cephalosporins, have also spread among E. coli clinical isolates. 2 These enzymes are unable to hydrolyse cephamycins with an -methoxy substituent in the C7 position, such as cefoxitin and cefotetan. 3 E. coli resistance to cefoxitin is considered uncommon and is usually attributed to overexpression of the species-specific chromosomal cephalosporinase. 4 The emergence of plasmid-mediated -lactamases with chromosomal cephalosporinase characteristics has been reported mostly in Klebsiella pneumoniae and, to a lesser extent, in E. coli. On the basis of sequence homologies, it appears that LAT-1, LAT-2 CMY-2 and BIL-1 -lactamases comprising the 'Mediterranean -Middle East' cluster have been derived from the species-specific chromosomal cephalosporinase of Citrobacter freundii. 5 The LAT-1, LAT-2 and CMY-2 enzymes were found in K. pneumoniae strains isolated in hospitals in Athens; [6] [7] [8] BIL-1 was from an isolate of E. coli possibly acquired in Pakistan. 9 An invariable phenotypic trait of E. coli strains producing these -lactamases is resistance to cefoxitin. Recent records of the Greek WHO-Net Study Group indicate that the current incidence of cefoxitin resistance among E. coli isolates in Athens hospitals is 3%. In this study we show that the predominant mechanism of resistance to cefoxitin in these isolates is the production of transferable C. freundii-derived cephalosporinases.
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Transferable class C -lactamases in Escherichia coli strains isolated in
Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC -lactamase
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Materials and methods
Bacterial isolates
A total of 2133 non-repetitive E. coli isolates were initially checked. Isolates were identified at the species level by either API20E (BioMerieux, Marcy-l'Etoile, France) or the PASCO System (Difco Laboratories, Detroit, MI, USA). They came from 10 hospitals located in the Athens area and represented the entire number of E. coli isolates obtained from hospitalized patients with active infection during the period from January 1996 to February 1997.
Screening for resistance to cefoxitin and determination of MICs of -lactams
The screening for resistance to cefoxitin was performed using discs containing 30 g of the antibiotic. Isolates were considered to be resistant to cefoxitin if the diameter of the inhibition zone was 14 mm. Minimum inhibitory concentrations of various -lactam antibiotics were determined using Etest strips according to the instructions of the manufacturer (AB BioDisk, Solna, Sweden).
Typing of the isolates
The ERIC2-PCR method was applied to type the cefoxitin-resistant E. coli isolates. 10 Extracted genomic DNA (approximately 100 ng from each isolate) was amplified in a final volume of 50 L containing 20 mM Tris-HCl (pH 8.3), 50 mM KCl, 0.2 mM (each) deoxynucleoside triphosphate, 2 mM MgCl 2 , 50 pmol of the ERIC2 primer (5 -AAGTAAGTGACTGGGGTGAGCG-3 ), and 0.5 Units of Taq DNA polymerase (Promega, Madison, WI, USA). The PCR products were separated in 1.2% agarose.
Transfer of resistance to antibiotics and isolation of plasmids
Resistance to cefoxitin was transferred either by transformation using E. coli XL1 Blue competent cells or by conjugation with the recipient strain E. coli 26R793 (Rif r , lac -) as described previously. 6 Transformants and transconjugant clones were selected on nutrient agar containing cefoxitin (25 mg/L). Isolation of plasmids from transformant and transconjugant clones was performed using an alkaline lysis procedure. 11 Plasmids were purified from low-melting-point agarose according to standard protocols. 12 
Hybridization with an LAT-specific probe
To detect genes encoding LAT-like class C -lactamases among cefoxitin-resistant E. coli, a dot hybridization procedure was followed. The LAT-specific probe was a 288 bp SacII-MluI fragment of the plasmid pBL23. 13 The probe was internal to the LAT-1 cephalosporinase coding region. It was labelled by random primer incorporation of digoxigenin-dUTP (Boehringer-Mannheim, Mannheim, Germany). Plasmid DNA preparations were immobilized on Hybond-C filters (Amersham, Little Chalfont, UK) and hybridized with the probe under highly stringent conditions (20 SSC [1 SSC is 0.15 M NaCl plus 0.015 M sodium citrate], 65°C). The plasmids pBL23 and pBCSK (Stratagene, La Jolla, CA, USA) were used as positive and negative controls, respectively.
Cloning of bla and bla and determination of gene sequence EcoRI-BamHI fragments of the plasmids pMEL1 and pMEL2 that contained the bla LAT-3 and bla LAT-4 genes were directly cloned into the chloramphenicol-resistant phagemid pBCSK . The nucleotide sequence was determined by the dideoxy chain termination method 14 with a Sequenase 2.0 kit (USB-Amersham, Cleveland, OH, USA) using a set of custom and universal oligonucleotide primers. The nucleotide sequences of both strands were determined. The sequences were assembled and analysed with the PCGENE software package. Similarities were searched for using the EMBL and Swissprot databases.
Extraction and quantitation of -lactamases
-Lactamase crude preparations were obtained after mild ultrasonic treatment of mid-log phase bacterial cultures in Tryptone-Soya broth. 6 The lysates were clarified by ultracentrifugation and desalted. The protein content of the extracts was measured using the Bio-Rad Protein Assay Kit (Bio-Rad Laboratories, München, Germany). The -lactamase content was assessed by measuring cephaloridine hydrolysis rates spectrophotometrically at 295 nm, expressing them as units of activity (1 U 1 mol of cephaloridine hydrolysed per minute per mg of protein at pH 7.0 and 37°C).
Isoelectric focusing
Isoelectric focusing (IEF) of -lactamase preparations was performed in polyacrylamide gels containing ampholytes (pH range 3.5-9.5) (Pharmacia-LKB, Uppsala, Sweden).
-Lactamase bands were visualized with nitrocefin (Oxoid Ltd, Basingstoke, UK). Cell extracts containinglactamases with known pIs were used as controls. 7 
Hydrolysis and inhibition studies
Hydrolytic activity against -lactams and determination of maximum rates of hydrolysis (V max ) were studied by UV spectrophotometry. 7 The V max values were expressed as hydrolysis rates relative to that of cephaloridine, which was set at 100. The concentrations of clavulanic acid, sulbactam, tazobactam, and the novel penam sulphone Ro 48-1220 that inhibited 50% of the enzymatic activity against nitrocefin were assessed as described previously. 15 
Outer-membrane protein analysis
Outer-membrane protein (OMP) preparations were obtained after selective solubilization and removal of cytoplasmic material from sonicated cell suspensions with sodium n-lauryl sarcosinate (Sigma-Aldrich, Deisenhofen, Germany). 16 The preparations were run on discontinuous SDS-polyacrylamide gels and stained with Coomassie Brilliant Blue R-250.
Results
As shown in Table I , 63 out of 2133 E. coli clinical isolates (3%) were resistant to cefoxitin (FOX r ). Percentages ranging from 1.5% to 5.8% were observed in the participating hospitals. Most of the FOX r isolates were from patients in the medical wards. The sporadic mode of isolation indicated the lack of outbreaks, and typing by ERIC2-PCR confirmed that the isolates were distinct (data not shown). Apparent associations between the isolation of cefoxitin-resistant E. coli and patients' characteristics or previous antibiotic treatment were not observed.
Several patterns of resistance to -lactams were observed for the FOX r isolates (Table II) . Fifty-five isolates displayed a significant decrease in susceptibility to ceftazidime, cefotaxime, aztreonam, amoxycillinclavulanate, and piperacillin-tazobactam compared with cefoxitin-susceptible E. coli strains such as EcS. Analysis of their -lactamase content showed that they produced enzymes with pIs of either 8.9 or 9.4, which were designated LAT-3 and LAT-4, respectively. The substrate and inhibition profiles of the latter enzymes (Tables III  and IV) , taken together with the positive hybridization of the respective plasmid preparations with the LAT-specific probe (data not shown), indicated that the enzymes belonged to class C and were related to the chromosomal cephalosporinase of C. freundii. The level of resistance to -lactams was associated with the amounts of -lactamase produced. In eight of the 55 cephalosporinase producers, elevated MICs of cefepime were also observed. These isolates produced an additional -lactamase co-focusing with SHV-5 at 8.2. In the remaining eight FOX r isolates the MICs of other -lactams were slightly elevated and SDS-PAGE of outer-membrane preparations showed that these isolates lacked a 36 kDa major protein, presumably a porin (Figure 1 ).
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Conjugal transfer of resistance to cefoxitin to susceptible E. coli recipients was achieved in only a few cases. Successive mating experiments using the transconjugant clones as donors showed that the LAT-encoding plasmids were not self-transmissible but that they could be mobilized by coexisting conjugative R plasmids. The LAT-3 and LAT-4 encoding plasmids had restriction patterns similar to those of the previously characterized LAT-1 and LAT-2 encoding plasmids found in K. pneumoniae. Their size was approximately 8.5 kb (data not shown).
Two plasmids, designated pMEL1 and pMEL2, encoding LAT-3 and LAT-4, respectively, were isolated from low-melting-point agarose. The -lactamase genes, located on 2.7 kb EcoRI-BamHI fragments, were cloned into the multicloning site of the phagemid pBCSK and the respective bla sequences were determined. In both sequences an ATG codon initiated an open reading frame of 1146 nucleotides which terminated with a TAA codon followed by a potential terminator hairpin. The open reading frames were preceded by a ribosome-binding sequence (AcGGAacT) and possible -35 (TTGTCA) and -10 (CACACT) promoter regions. The sequences shared a high degree of homology with the C. freundii OS60 ampC gene. In the upstream sequence a 110 bp segment similar to a part of the ampR-ampC intercistronic region of C. freundii was detected (from nucleotide 12 to nucleotide 122) (Figure 2 ). The deduced amino acid plasmid-encoded cephalosporinases (Table V) . LAT-3 differed from LAT-4 by seven amino acids. On the basis of sequence similarities and hydropathy plots, it was postulated that the signal peptides consisted of the initial 20 residues. Amino acid residues such as S64, K67, K315 and G317, which are considered important for the catalytic activity of C. freundii AmpC -lactamase, 19 were also present in LAT-3 and LAT-4 ( Figure 2 ). 
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Table V. Per cent homologies of the amino acid sequences of LAT-1, LAT-2, LAT-3, LAT-4, BIL-1, CMY-2 and C. freundii OS60 AmpC
Discussion
In this study it was shown that the increasing incidence of cefoxitin-resistant E. coli isolates observed recently in Greek hospitals results mainly from the spread of plasmids encoding -lactamases similar to the chromosomal cephalosporinase of C. freundii. Several plasmid-mediated class C -lactamases originating from E. cloacae (MIR-1 and ACT-1), 20, 21 Pseudomonas aeruginosa (CMY-1, FOX-1, FOX-2 and MOX-1), 5, [22] [23] [24] or C. freundii (BIL-1, CMY-2, LAT-1 and LAT-2) [6] [7] [8] 18 have been found in clinical isolates of K. pneumoniae and E. coli. Sequence data showed that the LAT-3 and LAT-4 -lactamases are variants of the AmpC -lactamase of C. freundii. The enzymes behaved as typical cephalosporinases, hydrolysing classical cephalosporins faster than penicillins. The amino acid differences between the C. freundii AmpCderived -lactamases do not appear to influence the catalytic efficiency of the enzymes. This fact indicates that these class C enzymes, unlike penicillinases of the TEM and SHV types, can tolerate a wide variety of point mutations without alteration of their kinetic profiles. As expected, the LAT-3 and LAT-4 -lactamases hydrolysed the newer oxyimino cephalosporins at low rates. However, they conferred a derepressed-like phenotype in isolates able to produce them in large amounts. The variation in production of the LAT-3 and LAT-4 enzymes expressed from the E. coli strains is of interest. The respective plasmids exhibited similar restriction patterns (data not shown), but may differ in the way they control the level of constitutive -lactamase production. Alternatively, differences in -lactamase levels may be attributed to host-plasmid interaction. The latter explanation is more likely, since the E. coli XL1-Blue transformed with LATencoding plasmids expressed similar quantities of each -lactamase, irrespective of the level of enzyme produced in the wild strains.
As with most plasmid-borne ampC genes, the mode of translocation of bla LAT genes from the chromosome of C. freundii to plasmids has not been elucidated. Only the P. aeruginosa AmpC-related MOX-1 -lactamase has been clearly associated with an integron-like element. 24 It has also been found that the E. cloacae-derived bla ACT-1 gene is located in plasmids as well as in the chromosome of K. pneumoniae, suggesting its association with a transposable element. 21 One study has reported the presence of C. freundii ampC-related genes in transmissible R-factors harboured by C. freundii. 25 However, we have failed in repeated attempts to detect either plasmid-mediated cephalosporinases or plasmids homologous with those encoding LAT -lactamases in clinical isolates of C. freundii (unpublished observations). Whatever the mechanism of translocation of bla LAT genes, the respective plasmids were mobilized by large conjugative plasmids coding for extended-spectrum -lactamases as observed here and in previous studies. 6, 7 The selective resistance to cefoxitin and cefotetan offered by plasmid-mediated AmpC enzymes like LAT-3 and LAT-4 led to the frequent use of the term 'cephamycinase'. This term, however, may not depict accurately the antibiotic pressure that facilitated their spread in our clinical setting. The use of cefoxitin in perioperative prophylaxis is limited, and cefotetan has not been introduced in Greek hospitals. As can be seen from the -lactam resistance phenotype, LAT-3 and LAT-4 -lactamases decreased the susceptibility of E. coli isolates to various -lactams, such as third-generation cephalosporins and amoxycillin-clavulanate, which are extensively used in hospitals. The combination of piperacillin with tazobactam exerted good in-vitro activity against LAT-3 and LAT-4 producing isolates of E. coli. This must be attributed to the moderated inhibitory activity of tazobactam against the class C enzymes, 26 as well as to the fact that piperacillin is not a preferred substrate for these enzymes. It must be noted that in isolates producing relatively low quantities of the LAT cephalosporinases the MICs of -lactams, with the exception of cefoxitin, did not exceed the respective breakpoints. These isolates may therefore pass unnoticed when the susceptibility status is determined by semiquantitative systems not including cefoxitin.
Decreased permeability of the outer membrane has also been suggested as a mechanism of resistance to cefoxitin in E. coli. 27 This is likely to be the mechanism of resistance to cefoxitin in the few isolates that had lost a major outermembrane protein. E. coli permeability mutants lacking outer-membrane proteins can be easily selected with cefoxitin. As has also been reported previously, 28 the degree of reduced susceptibility to newer -lactams is low. In addition, loss of a major porin species may delay the uptake of nutrients, thereby decreasing the competence of the respective bacteria. This may explain the scarcity of -lactam-resistant E. coli clinical isolates with porin deficiency, which, as observed here, appear sporadically but cannot become established in the hospital flora.
Sequence accession numbers
The accession numbers of the bla LAT-3 and bla nucleotide sequences in the EMBL Data Bank are Y15411 and Y15412, respectively.
